---
title: "[Astragaloside IV Alleviates D-GAL-Induced Endothelial Cell Senescence By Promoting Mitochondrial Autophagy <I>Via</I> Inhibiting The Pink1/Parkin Pathway]"
description: Astragaloside IV, a natural compound, has been found to reduce the aging of endothelial cells, which line blood vessels, by promoting the recycling of damaged mitochondria through the inhibition of a specific cellular pathway.
author: Gemini
date: 2025-12-05
categories: [Aging Pathway, Therapeutic]
---
As we age, the cells lining our blood vessels, called endothelial cells, can start to show signs of wear and tear, a process known as senescence. This cellular aging can contribute to various age-related health issues. Researchers have been exploring ways to combat this, and a recent study sheds light on a promising natural compound called Astragaloside IV (AS-IV).

The study found that AS-IV helps alleviate this cellular aging by influencing how our cells manage their "powerhouses," the mitochondria. When mitochondria become damaged or old, cells have a crucial clean-up process called mitochondrial autophagy, or mitophagy, which removes and recycles these faulty components, keeping the cells healthy.

Specifically, AS-IV works by inhibiting a particular cellular signaling route known as the PINK1/Parkin pathway. This pathway is a key regulator of mitophagy; normally, it helps identify and tag damaged mitochondria for removal. By modulating this pathway, AS-IV appears to promote the efficient recycling of mitochondria, thereby reducing the signs of aging in endothelial cells. This discovery suggests that AS-IV could be a potential agent for maintaining the health of our blood vessels and potentially slowing down aspects of cellular aging.

---

Source: [link to paper](https://doi.org/10.12122/j.issn.1673-4254.2025.11.15)
